Marc Tessier-Lavigne Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Tessier-Lavigne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Tessier-Lavigne. Marc Tessier-Lavigne is EVP, RESEARCH DRUG DISCOVERY in GENENTECH INC ($DNA) and Director in PFIZER INC ($PFE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Denali Therapeutics Inc. ($DNLI).
Marc Tessier-Lavigne in REGENERON PHARMACEUTICALS, INC.
Trading Symbol: REGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 2,078 shares
Current Value: $743,280
Latest Transaction: Jan 05 2021
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Marc Tessier-Lavigne in REGENERON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, DNLI, DNA, JUNO, PFE, REGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 248 | 0 | 2,078 | 1.8 K to 2.1 K (+13.55 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 177.82 | 15,000 | 2,667,300 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 566.01 | 100 | 56,601 | 1,830 | 1.9 K to 1.8 K (-5.18 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 565.35 | 900 | 508,815 | 1,930 | 2.8 K to 1.9 K (-31.80 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 564.45 | 6,600 | 3,725,370 | 2,830 | 9.4 K to 2.8 K (-69.99 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 563.45 | 6,375 | 3,591,994 | 9,430 | 15.8 K to 9.4 K (-40.34 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 562.65 | 1,025 | 576,716 | 15,805 | 16.8 K to 15.8 K (-6.09 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 177.82 | 15,000 | 2,667,300 | 16,830 | 1.8 K to 16.8 K (+819.67 %) |
Jan 06 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
Jan 06 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 320 | 0 | 1,830 | 1.5 K to 1.8 K (+21.19 %) |
Jan 05 2017 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 376.69 | 7,830 | 2,949,483 | 7,830 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 57.11 | 5,000 | 285,550 | 5,000 | |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 595.44 | 500 | 297,720 | 1,187 | 1.7 K to 1.2 K (-29.64 %) |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 593.64 | 2,000 | 1,187,280 | 1,687 | 3.7 K to 1.7 K (-54.24 %) |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 590.17 | 1,000 | 590,170 | 3,687 | 4.7 K to 3.7 K (-21.34 %) |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 584.07 | 1,500 | 876,105 | 4,687 | 6.2 K to 4.7 K (-24.24 %) |
Aug 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 57.11 | 5,000 | 285,550 | 6,187 | 1.2 K to 6.2 K (+421.23 %) |
Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 50.91 | 3,000 | 152,730 | 9,279 | |
Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 424.44 | 300 | 127,332 | 1,187 | 1.5 K to 1.2 K (-20.17 %) |
Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 423.64 | 1,100 | 466,004 | 1,487 | 2.6 K to 1.5 K (-42.52 %) |
Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 420.33 | 1,600 | 672,528 | 2,587 | 4.2 K to 2.6 K (-38.21 %) |
Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 50.91 | 3,000 | 152,730 | 4,187 | 1.2 K to 4.2 K (+252.74 %) |
Page: 1